← Back to Patent Explorer
US4265233A Expired / Lapsed US ⏱️ 0.0 years remaining

Material for wound healing

Assignee: Unitika Ltd
•
Filing: 1979-04-06
•
Granted: 1981-05-05
•
Expires: 1999-04-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A wound healing material having blood coagulation Factor XIII fixed thereto. This material promotes the formation of stabilized fibrin at a wound site and is effective for a long period of time, thereby protecting the wound and promoting its healing.

Inventors

  • 👤 Akio Sugitachi
  • 👤 Kunihiko Takagi
  • 👤 Yasunori Yabushita

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 20:55
CPC Classifications
A; A61; A61L; A61L15/00; A61L15/16; A61L15/42; A61L15/44; A61L15/64; A61L17/00; A61L17/005; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/418; A61L2300/45; A61L2400/00; A61L2400/04

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 42 words
A wound healing material capable of effectively promoting the formation of stabilized fibrin at a wound site over a long period of time, said material comprising a structure having a substance fixed thereto, said substance consisting essentially of blood coagulation Factor XIII.
Claim 2
Dependent Claim 42 words
A wound healing material capable of effectively promoting the formation of stabilized fibrin at a wound site over a long period of time, said material comprising a structure having a substance fixed thereto, said substance consisting essentially of blood coagulation Factor XIII.
Claim 3
Dependent Claim 13 words
The healing material of claim 1, wherein the structure is an absorbable material.
Claim 4
Dependent Claim 12 words
The healing material of claim 2, wherein the absorbable material is gelatin.
Claim 5
Dependent Claim 12 words
The healing material of claim 2, wherein the absorbable material is collagen.
Claim 6
Dependent Claim 13 words
The healing material of claim 2, wherein the absorbable material is polyglycolic acid.
Claim 7
Dependent Claim 13 words
The healing material of claim 2, wherein the absorbable material is polylactic acid.
Claim 8
Dependent Claim 23 words
The healing material of claim 1, wherein said Factor XIII is fixed in an amount sufficient to promote the formation of stabilized fibrin.
Claim 9
Dependent Claim 44 words
A wound healing material capable of effectively promoting the formation of stabilized fibrin at a wound site over a long period of time, said material comprising a structure having a substance fixed thereto, said substance consisting essentially of blood coagulation Factor XIII and thrombin.
Claim 10
Dependent Claim 44 words
A wound healing material capable of effectively promoting the formation of stabilized fibrin at a wound site over a long period of time, said material comprising a structure having a substance fixed thereto, said substance consisting essentially of blood coagulation Factor XIII and thrombin.
Claim 11
Dependent Claim 13 words
The healing material of claim 8, wherein the structure is an absorbable material.
Claim 12
Dependent Claim 12 words
The healing material of claim 9, wherein the absorbable material is gelatin.
Claim 13
Dependent Claim 12 words
The healing material of claim 9, wherein the absorbable material is collagen.
Claim 14
Dependent Claim 13 words
The healing material of claim 9, wherein the absorbable material is polyglycolic acid.
Claim 15
Dependent Claim 13 words
The healing material of claim 9, wherein the absorbable material is polylactic acid.
Claim 16
Dependent Claim 24 words
The healing material of claim 8, wherein said Factor XIII and thrombin are fixed in amounts sufficient to promote the formation of stabilized fibrin.
Claim 17
Dependent Claim 17 words
The healing material of claims 1 or 8, wherein calcium ion is additionally fixed to the structure.
Claim 18
Dependent Claim 17 words
The healing material of claims 1 or 8, wherein a pharmaceutical is additionally fixed to the structure.
Claim 19
Dependent Claim 22 words
The healing material of claim 16, wherein said pharmaceutical is selected from the group consisting of antiplasmins, antibiotics, antivirals, sulfanamides and anti-infectives.
Claim 20
Dependent Claim 26 words
The healing material of claim 1 or 8, wherein said structure is in the form of a mono-filament, a fibrous assembly, a film, or a sponge.
Claim 21
Dependent Claim 16 words
The healing material of claim 1 or 8, wherein said healing material is a surgical suture.
Claim 22
Dependent Claim 15 words
The healing material of claim 1 or 8, wherein said healing material is a dressing.
Claim 23
Dependent Claim 15 words
The healing material of claim 1 or 8, wherein said healing material is a bandage.
Claim 24
Dependent Claim 15 words
The healing material of claim 1 or 8, wherein said healing material is a sponge.
Claim 25
Dependent Claim 20 words
The healing material of claim 1 or 8, wherein said healing material is a filling for a tooth extracted cavity.
Claim 26
Dependent Claim 16 words
The healing material of claim 2 or 9, wherein said healing material is a gelatin sponge.

References Cited (Backward Citations)

US2533004A Cited
US2465357A Cited
US2512616A Cited
US2772999A Cited
US3249109A Cited
US3419006A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-05-04 1984-11-03 1985-05-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-05-04 1988-11-03 1989-05-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-05-04 1992-11-03 1993-05-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag